Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Zeria Pharmaceutical Co. Ltd.
DescriptionRapid test that detects celiac disease associated IgA and IgG antibodies against a unique combination of deamidated gliadin peptides (DGP)
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationAutoimmune, Diagnostic
Indication DetailsDiagnose celiac disease
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today